KAKEN PHARMACEUTICAL CO.,LTD. 4521Short Interest
No institution currently reports a short position of 0.5% or more in KAKEN PHARMACEUTICAL CO.,LTD. (4521). The last disclosure was on 2026-09-15 (BNP Paribas Financial Markets SNC, 0.39%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
30 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 5 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2021-05-13 |
|---|---|
| Latest disclosure | 2026-09-15 (BNP Paribas Financial Markets SNC, 0.39%) |
| Reporting institutions | 5 firms (30 reports) |
| Peak estimated short interest | 1.03% (2021-05-25, 2 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 4 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- J.P. MORGAN SECURITIES PLC
- Citigroup Global Markets Limited
- BNP Paribas Financial Markets SNC
- Integrated Core Strategies (Asia) Pte. Ltd.
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2021-06-02 | GOLDMAN SACHS INTERNATIONAL | Position 218,765 shares | Ratio 0.47% | ▼0.05% | Below 0.5% |
| 2025-06-20 | J.P. MORGAN SECURITIES PLC | Position 211,507 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2026-09-15 | BNP Paribas Financial Markets SNC | Position 173,500 shares | Ratio 0.39% | ▼0.19% | Below 0.5% |
| 2023-08-30 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 172,703 shares | Ratio 0.37% | ▼0.14% | Below 0.5% |
| 2026-07-31 | Citigroup Global Markets Limited | Position 64,835 shares | Ratio 0.14% | ▼0.39% | Below 0.5% |
Disclosure History 30 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-09-15 | BNP Paribas Financial Markets SNC | Position 173,500 shares | Ratio 0.39% | ▼0.19% | Below 0.5% |
| 2026-09-14 | BNP Paribas Financial Markets SNC | Position 259,100 shares | Ratio 0.58% | ▲0.58% | — |
| 2026-07-31 | Citigroup Global Markets Limited | Position 64,835 shares | Ratio 0.14% | ▼0.39% | Below 0.5% |
| 2026-07-29 | Citigroup Global Markets Limited | Position 237,935 shares | Ratio 0.53% | ▲0.11% | — |
| 2026-07-17 | Citigroup Global Markets Limited | Position 130,689 shares | Ratio 0.29% | ▼0.24% | Below 0.5% |
| 2026-07-15 | Citigroup Global Markets Limited | Position 238,189 shares | Ratio 0.53% | ▼0.11% | — |
| 2026-07-08 | Citigroup Global Markets Limited | Position 283,689 shares | Ratio 0.64% | ▲0.05% | — |
| 2026-07-07 | Citigroup Global Markets Limited | Position 262,789 shares | Ratio 0.59% | ▲0.25% | — |
| 2026-05-27 | BNP Paribas Financial Markets SNC | Position 109,000 shares | Ratio 0.24% | ▼0.28% | Below 0.5% |
| 2026-05-22 | BNP Paribas Financial Markets SNC | Position 231,000 shares | Ratio 0.52% | ▲0.52% | — |
| 2026-02-17 | Citigroup Global Markets Limited | Position 197,743 shares | Ratio 0.44% | ▼0.13% | Below 0.5% |
| 2026-02-12 | Citigroup Global Markets Limited | Position 252,643 shares | Ratio 0.57% | ▼0.11% | — |
| 2026-02-09 | Citigroup Global Markets Limited | Position 301,943 shares | Ratio 0.68% | ▼0.02% | — |
| 2026-02-06 | Citigroup Global Markets Limited | Position 312,743 shares | Ratio 0.70% | ▲0.03% | — |
| 2026-02-05 | Citigroup Global Markets Limited | Position 299,443 shares | Ratio 0.67% | ▲0.11% | — |
| 2026-02-04 | Citigroup Global Markets Limited | Position 249,443 shares | Ratio 0.56% | ▲0.13% | — |
| 2025-06-20 | J.P. MORGAN SECURITIES PLC | Position 211,507 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2025-06-18 | J.P. MORGAN SECURITIES PLC | Position 221,907 shares | Ratio 0.50% | ▲0.01% | — |
| 2025-06-12 | J.P. MORGAN SECURITIES PLC | Position 219,207 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2025-06-10 | J.P. MORGAN SECURITIES PLC | Position 220,707 shares | Ratio 0.50% | ▲0.01% | — |
| 2025-06-03 | J.P. MORGAN SECURITIES PLC | Position 216,407 shares | Ratio 0.49% | ▼0.35% | Below 0.5% |
| 2025-06-02 | J.P. MORGAN SECURITIES PLC | Position 374,907 shares | Ratio 0.84% | ▲0.44% | — |
| 2023-08-30 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 172,703 shares | Ratio 0.37% | ▼0.14% | Below 0.5% |
| 2023-08-15 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 237,440 shares | Ratio 0.51% | ▲0.10% | — |
| 2021-06-02 | GOLDMAN SACHS INTERNATIONAL | Position 218,765 shares | Ratio 0.47% | ▼0.05% | Below 0.5% |
| 2021-05-27 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 60,100 shares | Ratio 0.13% | ▼0.38% | Below 0.5% |
| 2021-05-25 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 237,800 shares | Ratio 0.51% | ▲0.10% | — |
| 2021-05-25 | GOLDMAN SACHS INTERNATIONAL | Position 241,064 shares | Ratio 0.52% | ▲0.08% | — |
| 2021-05-18 | GOLDMAN SACHS INTERNATIONAL | Position 203,865 shares | Ratio 0.44% | ▼0.06% | Below 0.5% |
| 2021-05-13 | GOLDMAN SACHS INTERNATIONAL | Position 231,965 shares | Ratio 0.50% | ▲0.09% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |